You are here

Whole-Exome Sequencing Study Identifies Four Novel Gene Loci Associated with Diabetic Kidney Disease.

TitleWhole-Exome Sequencing Study Identifies Four Novel Gene Loci Associated with Diabetic Kidney Disease.
Publication TypeJournal Article
Year of Publication2022
AuthorsPan, Y, Sun, X, Mi, X, Huang, Z, Hsu, Y, Hixson, JE, Munzy, D, Metcalf, G, Franceschini, N, Tin, A, Köttgen, A, Francis, M, Brody, JA, Kestenbaum, B, Sitlani, CM, Mychaleckyj, JC, Kramer, H, Lange, LA, Guo, X, Hwang, S-J, Irvin, MR, Smith, JA, Yanek, LR, Vaidya, D, Chen, Y-DI, Fornage, M, Lloyd-Jones, DM, Hou, L, Mathias, RA, Mitchell, BD, Peyser, PA, Kardia, SLR, Arnett, DK, Correa, A, Raffield, LM, Vasan, RS, L Cupple, A, Levy, D, Kaplan, RC, North, KE, Rotter, JI, Kooperberg, C, Reiner, AP, Psaty, BM, Tracy, RP, Gibbs, RA, Morrison, AC, Feldman, H, Boerwinkle, E, He, J, Kelly, TN
Corporate/Institutional AuthorsNHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, TOPMed Kidney Function Working Group, CRIC Study Investigators
JournalHum Mol Genet
Date Published2022 Nov 29
Abstract<p>Diabetic kidney disease (DKD) is recognized as an important public health challenge. However, its genomic mechanisms are poorly understood. To identify rare variants for DKD, we conducted a whole-exome sequencing (WES) study leveraging large cohorts well-phenotyped for chronic kidney disease (CKD) and diabetes. Our two-stage whole-exome sequencing study included 4372 European and African ancestry participants from the Chronic Renal Insufficiency Cohort (CRIC) and Atherosclerosis Risk in Communities (ARIC) studies (stage-1) and 11 487 multi-ancestry Trans-Omics for Precision Medicine (TOPMed) participants (stage-2). Generalized linear mixed models, which accounted for genetic relatedness and adjusted for age, sex, and ancestry, were used to test associations between single variants and DKD. Gene-based aggregate rare variant analyses were conducted using an optimized sequence kernel association test (SKAT-O) implemented within our mixed model framework. We identified four novel exome-wide significant DKD-related loci through initiating diabetes. In single variant analyses, participants carrying a rare, in-frame insertion in the DIS3L2 gene (rs141560952) exhibited a 193-fold increased odds (95% confidence interval: 33.6, 1105) of DKD compared with non-carriers (P = 3.59 × 10-9). Likewise, each copy of a low-frequency KRT6B splice-site variant (rs425827) conferred a 5.31-fold higher odds (95% confidence interval: 3.06, 9.21) of DKD (P = 2.72 × 10-9). Aggregate gene-based analyses further identified ERAP2 (P = 4.03 × 10-8) and NPEPPS (P = 1.51 × 10-7), which are both expressed in the kidney and implicated in renin-angiotensin-aldosterone system modulated immune response. In the largest WES study of DKD, we identified novel rare variant loci attaining exome-wide significance. These findings provide new insights into the molecular mechanisms underlying DKD.</p>
Alternate JournalHum Mol Genet
PubMed ID36444934
Grant ListR01 DK117445 / DK / NIDDK NIH HHS / United States
R01 MD012765 / MD / NIMHD NIH HHS / United States
ePub date: